Table 3.
Characteristic of patients with JIA according to type of JIA and control group.
| Polyarticular, n = 14 | Oligoarticular, n = 16 | Control group, n = 20 | P | |
|---|---|---|---|---|
| Age, years | 14,9 ± 1,6 | 13,3 ± 1,8 | 14,4 ± 1,8 | 0.0441 |
| Female | 10 (71,4%) | 13 (81,2%) | 15 (75,0%) | 0.8427 |
| Weight, kg | 50,6 ± 7,1 | 46,4 ± 9,5 | 55,5 ± 9,0 | 0.0109*
P versus O: 0.0083 |
| Height, cm | 163,2 ± 5,5 | 158,4 ± 10,7 | 166,0 ± 10,3 | 0.0665 |
| BMI | 19,0 ± 2,3 | 18,3 ± 2,1 | 20,1 ± 2,3 | 0.0699, P versus O: 0.0606 |
| BMI percentile | 36,5 ± 27,0 | 37,9 ± 21,0 | 52,9 ± 25,6 | 0.0985 |
| FAT % | 19,9 ± 6,3 | 19,9 ± 5,5 | 23,0 ± 5,5 | 0.1745 |
| Total cholesterol, mg/dL | 145,6 ± 26,2 | 156,4 ± 23,7 | 153,4 ± 26,8 | 0.5022 |
| Triglycerides, mg/dL | 78,4 ± 30,0 | 99,0 ± 43,8 | 92,1 ± 37,3 | 0.3293 |
| LDL cholesterol, mg/dL | 77,1 ± 25,9 | 77,9 ± 22,4 | 77,6 ± 23,9 | 0.9961 |
| HDL cholesterol, mg/dL | 58,2 ± 14,1 | 58,7 ± 13,9 | 57,4 ± 14,9 | 0.9605 |
| hsCRP, mg/L | 0,70 [0,40–3,90] | 0,40 [0,25–0,55] | 0,45 [0,30–0,70] | 0.0962 |
| IL-6, pg/mL | 150,5 [0,0–239,6] | 0,0 [0–369,6] | 0 [0,0-0,0] | 0.0327 CG versus P: 0.0067 |
| Homocysteine, µmol/L | 8,6 ± 2,5 | 9,2 ± 3,2 | 9,2 ± 2,5 | 0.8209 |
| IMT, mm | 0,46 ± 0,03 | 0,48 ± 0,05 | 0,47 ± 0,04 | 0.3418 |
BMI: body mass index, % FAT: % body fat, LDL: low density lipoprotein, HDL: high density lipoprotein, hsCRP: high sensitivity lipoprotein, IL-6: interleukin 6, IMT: intima media thickness, *statistically significant, P: polyarticular, and O: oligoarticular.